Generally, younger age is considered a favorable prognostic factor in patients with IDH mutant gliomas; however, compared to pediatric and adult cohorts AYA have an inferior survival (Lim-Fat et al., 2024) as is the case for other cancer types. This evidence concerns the gene IDH2 and central nervous system cancer.